Conclusion: the combined application of ct and serum tumor markers in ovarian carcinoma detection could improve the sensitivity of diagnosis and its consistency with clinical staging.

Differences of thymopoietin expression in ovarian cancer with different histological grade, clinical stage, metastasis and pathological types were not statistically significant.